5681 - 5690 of 6230 Results
Title
Year
- Serum Neurofilament Light is elevated in COVID-19 Positive Adults in the ICU and is associated with Co-Morbid Cardiovascular Disease, Neurological Complications, and Acuity of Illness2021OPENTitle: Serum Neurofilament Light is elevated in COVID-19 Positive Adults in the ICU and is associated with Co-Morbid Cardiovascular Disease, Neurological Complications, and Acuity of IllnessJournal Name: Cardiology and Cardiovascular MedicinePublisher: Fortune JournalsVol: 05Issue #: 05Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.26502/fccm.92920221Best OA location URL: https://doi.org/10.26502/fccm.92920221Citation Count: 14
- Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy2021OPENTitle: Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid AngiopathyJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.658605Best OA location URL: https://doi.org/10.3389/fnagi.2021.658605Citation Count: 14
- Temporal Ordering of Inflammatory Analytes sTNFR2 and sTREM2 in Relation to Alzheimer's Disease Biomarkers and Clinical Outcomes2021OPENTitle: Temporal Ordering of Inflammatory Analytes sTNFR2 and sTREM2 in Relation to Alzheimer's Disease Biomarkers and Clinical OutcomesJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.676744Best OA location URL: https://doi.org/10.3389/fnagi.2021.676744Citation Count: 13
- TNFRSF1B Gene Variants and Related Soluble TNFR2 Levels Impact Resilience in Alzheimer's Disease2021OPENTitle: TNFRSF1B Gene Variants and Related Soluble TNFR2 Levels Impact Resilience in Alzheimer's DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.638922Best OA location URL: https://doi.org/10.3389/fnagi.2021.638922Citation Count: 18
-
OPENTitle: Altered Brain Functional Network in Subtypes of Parkinson's Disease: A Dynamic PerspectiveJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.710735Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.710735/pdfCitation Count: 24
- Hippocampal and Hippocampal-Subfield Volumes From Early-Onset Major Depression and Bipolar Disorder to Cognitive Decline2021OPENTitle: Hippocampal and Hippocampal-Subfield Volumes From Early-Onset Major Depression and Bipolar Disorder to Cognitive DeclineJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.626974Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.626974/pdfCitation Count: 20
- A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study2021OPENTitle: A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 128End Page: 133Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.013Best OA location URL: http://www.prd-journal.com/article/S1353802021002625/pdfCitation Count: 24
- Motor Progression in Early-Stage Parkinson's Disease: A Clinical Prediction Model and the Role of Cerebrospinal Fluid Biomarkers2021OPENTitle: Motor Progression in Early-Stage Parkinson's Disease: A Clinical Prediction Model and the Role of Cerebrospinal Fluid BiomarkersJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.627199Best OA location URL: https://doi.org/10.3389/fnagi.2020.627199Citation Count: 13
-
OPENTitle: Plasma NfL, clinical subtypes and motor progression in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 41End Page: 47Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.016Citation Count: 42
- Clinical perception and management of Parkinson's disease during the COVID-19 pandemic: A Canadian experience2021OPENTitle: Clinical perception and management of Parkinson's disease during the COVID-19 pandemic: A Canadian experienceJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 66End Page: 76Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.08.018Best OA location URL: http://www.prd-journal.com/article/S1353802021003126/pdfCitation Count: 17